SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Concordium is the Layer-1 blockchain built for a new era of digital trust. With mandatory, privacy-preserving identity verification built into its consensus layer, utilizing zero-knowledge proof technology. Concordium also enables Protocol-level tokens that eliminate smart contract risks by being issued directly at the consensus layer, with built-in features that provide the infrastructure for compliance-ready use cases. At its core is Smart Money - programmable, identity-embedded, and compliance-ready value that powers trusted interactions across Web3. Smart Money enables frictionless exchange, automation, and verifiable trust by design. Unlike conventional blockchains, Concordium integrates trust, accountability, and privacy into its architecture from the ground up  bridging traditional systems and Web3 to build a transparent, sustainable digital future. The name Concordium comes from the Latin concordia—meaning harmony and agreement—a reflection of its mission to build infrastructure that embeds trust, privacy, and compliance into every interaction.

Concordium

Concordium ($CCD) is gaining traction as a privacy-focused layer-1 blockchain, with recent partnerships sparking increased interest and bullish sentiment. The community is highlighting its focus on regulatory compliance and real-world utility, differentiating it from hype-driven projects. Some users are drawing comparisons to ZCash ($ZEC) and anticipating significant growth potential.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR Protocol is gaining traction as community members highlight its growing user base, surpassing Solana and Ethereum in active users, which may be driving the current rally. Bullish sentiment is also fueled by discussions around AI integration and staking opportunities within the NEAR ecosystem. Traders are actively monitoring potential breakout setups and key price levels.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is trending as investors analyze recent stock transfers by the CEO to family trusts, speculating about potential buyout negotiations. The community is weighing the company's fundamentals, revenue growth, and potential catalysts like subq treatment data, with some expressing frustration over long-term returns and perceived market manipulation. Bullish sentiment persists due to Briumvi's market performance and potential, while bearish voices cite concerns about drug pricing and overall market conditions.

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Carmax Inc

CarMax ($KMX) is trending as the stock experiences volatility following CEO Bill Nash's resignation and a disappointing sales forecast, leading to community debate about the company's future and potential undervaluation. Some investors are weighing whether it's a buying opportunity, while others express concerns about subprime lending risks and comparisons to competitor Carvana. Analyst ratings are mixed, with some lowering price targets.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata Inc. is trending amid increasing community excitement around its potential in Sovereign AI and growing partnerships with major tech companies like Microsoft. Discussions center on the transformative potential of government and sovereign AI contracts, particularly in the Middle East, with institutions potentially viewing INOD as the next Nvidia. The community speculates on substantial revenue growth and a shift in business direction, from tech to government and AI.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The meme coin CAW (crow with knife) is trending as the community rallies around its fully circulated, multichain tokenomics and active development team. Conversations highlight its presence on Solana, Base, and other chains, with users emphasizing its strong community and deflationary burn mechanism. Community members are actively using the project's slogan 'caw caw caw'.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following segments: North America, Europe, Middle East and Africa (EMEA), Latin America, and Asia. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpool is trending amid community discussion around its valuation and potential triggers, including a possible Supreme Court ruling on tariffs and the progress of the Whirlpool of India divestment. Investors are weighing the impact of short positions, dividend prospects, and technical indicators like hammer candlesticks and rounded bottoms. Options activity and potential for a short squeeze are also being actively monitored.

Seagate Technology Holdings Plc operates as holding company that is engaged in the development, production, and distribution of data storage products and electronic data storage solutions. Its products include hard disk drives, solid state hybrid drives, solid state drives, peripheral component interconnect express cards, serial advanced technology attachment controllers, storage subsystems and computing solutions. The firm offers its products under the Backup Plus and Expansion product lines, and Maxtor and LaCie brands. The company was founded in 1978 and is headquartered in Fremont, CA.

Seagate Technology Holdings Plc

Seagate Technology ($STX) is trending as investors assess its potential in the AI-driven data storage market, with Bernstein upgrading the stock. Community discussions revolve around the sustainability of the memory and hard drive sector's gains, particularly compared to other tech stocks. Some traders point to technical indicators suggesting it may be overbought, while others highlight factors such as strong earnings and fund support.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

BSX is trending due to positive momentum in their electrophysiology and cardiovascular segments, prompting several analysts to raise price targets. The community is also discussing potential acquisitions and key resistance levels, with many noting the stock's consistent upward trend and strong technical setup. However, some are expressing concern about potential short-term pullbacks and recent insider selling.

4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. It combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences. Its product design, development and manufacturing engine create a valuable and diverse product pipeline. The company is currently advancing five clinical-stage and two preclinical product candidates, each tailored to address rare and large market diseases. 4DMT was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.

4D Molecular Therapeutics Inc

FDMT is trending due to positive 60-week data from its 4D-150 program in DME, sparking renewed investor interest and heavy trading volume. The community is discussing the potential for a short squeeze and analysts' high price targets, while also considering the possibility of a partnership or buyout. Attention is focused on the company's strong cash position and the acceleration of its Phase 3 trial for wet AMD.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$GME ..... |December sell off and trimming the record runs in the stock market buying will probably resume post new year. Play this stock based on fundamentals (shares, post Q4 options). Even beyond a squeeze, this company has a really great chance to transform. There is no one in the world that occupies the same space as them and their brand is renown. Even my fiancé who probably hasn’t stepped into a GameStop in the last 10 years knew them by name , “Aren’t they going bankrupt?” she said back in August. No baby, they most def ain’t going bankrupt. Let’s goooooooo ......|

Harate

Abc Def

Investments and Christ ✝️

No Problem

Matt

K2_ss

Peter van Inwagen

dogchasingcars

NoGamble

Colin Jameson

Tsanko

GoodMilkers

Tomislav

StockTwits for iOS

GameStop Corp

 ..... |December sell off and trimming the record runs in the stock market buying will probably resume post new year. Play this stock based on fundamentals (shares, post Q4 options). Even beyond a squeeze, this company has a really great chance to transform. There is no one in the world that occupies the same space as them and their brand is renown. Even my fiancé who probably hasn’t stepped into a GameStop in the last 10 years knew them by name , “Aren’t they going bankrupt?” she said back in August. No baby, they most def ain’t going bankrupt. Let’s goooooooo ......|

Slanted Angles

@Slantedangles I have January 15 calls $30 ... I don’t want to sell just to buy April, as April are up like 100% from last two days.. thoughts? I’m up about 250% on my calls but I was up 500% yesterday and I feel we will get back there

 I have January 15 calls $30 ... I don’t want to sell just to buy April, as April are up like 100% from last two days.. thoughts? I’m up about 250% on my calls but I was up 500% yesterday and I feel we will get back there

Michael

@Slantedangles any reco? Was my first ever call buys lol

 any reco? Was my first ever call buys lol

@Slantedangles this dd was so informative

StockTwits Web

@bluefuel to be honest now I’m not sure. Before today what I would’ve done is to see how much value you’re losing from the IV crush on those since they’re far OTM via options profit calculator. If the price held steady I saw an IV difference of about 40% from the week before and after earnings, you can model what that will do to the price in the options profit calculator. Maybe someone from the $GME board that’s more experienced can chime in. Right now I don’t know what the IV crush would be. For myself I have 10c January’s left which may play out a bit differently due to higher delta. I’m probably just going to hold through I’m here to make a milli I’m okay with the opportunity cost of 30-40k. I’ll roll mines out to July after.

 to be honest now I’m not sure. Before today what I would’ve done is to see how much value you’re losing from the IV crush on those since they’re far OTM via options profit calculator. If the price held steady I saw an IV difference of about 40% from the week before and after earnings, you can model what that will do to the price in the options profit calculator. Maybe someone from the 

 board that’s more experienced can chime in. Right now I don’t know what the IV crush would be. For myself I have 10c January’s left which may play out a bit differently due to higher delta. I’m probably just going to hold through I’m here to make a milli I’m okay with the opportunity cost of 30-40k. I’ll roll mines out to July after.

@JordynStarlight of course it is. I’m glad you can read.

 of course it is. I’m glad you can read.